Moreover, an unbiased transcriptomic approach revealed shared molecular signatures of an activated kidney TNF pathway and unfavorable clinical outcomes among patients diagnosed with either minimal change disease or focal segmental glomerulosclerosis, highlighting TNF as a pivotal driver in the progression of these diseases (38). Here, TNF is linked to focal segmental glomerulosclerosis.